Abstract
Exercise ECG is an established method of evaluating the anti-ischemic properties of drugs. However, there are considerable methodologic limitations to this procedure and its use is restricted to patients with exercise-provoked ECG alterations which can be interpreted as ischemia. The principal, earlier onset of wall motion abnormalities according to the ischemic cascade can be detected by stress echocardiography and might be utilized as a pharmacological stress testing modality. Sixteen consecutive patients (15 men, one woman; 53 ± 9 years old) with angiographically proven coronary artery disease (8 with one-, 5 with two-, and 3 with three-vessel disease) and exercise-induced wall motion abnormalities were examined by dynamic stress echocardiography (50 watt followed by 20-watt increases/min). Anti-ischemic drugs were withdrawn prior to and on day 1; on the following day 2, 0.2 µg/kg/min nisoldipine was infused intravenously during the test after a 3 µg/kg bolus was given. At maximum comparable workload 15/16 patients showed an improved wall motion score on treatment (day 1: 22.9 ± 4.9 vs day 2: 20.0 ± 3.9; normal score: 12; one-sided binomial test: p = 0.0003). Eight of 16 patients demonstrated ST-segment deviations on day 1 and day 2. The double product did not differ at any workload stage until the maximum of 130 watt (day 1: 14101 ± 3140 vs day 2: 13365 ± 2865; n.s.). Dynamic stress echocardiography seems to be a valuable tool in pharmacologic stress testing and in terms of accuracy is supposed to be superior to conventional exercise ECG. Nisoldipine reduces exercise-induced wall motion abnormalities in patients with and without exercise-induced ECG alterations. The data result from a controlled pilot study, and further studies are required to confirm these promising methodological and therapeutic findings.
Similar content being viewed by others
References
Borer JS, Brensika JF, Redwood DR, Itscoitz SB, Passamani ER, Strom NJ, Richardson JM, Levy RI, Epstein SE. Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N Engl J Med 1975; 293: 367–71.
Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, McArthur D, Froelicher V. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989; 80: 87–98.
Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, Di Bianco R, Bray J, Means WE, Morledge J, and Coinvestigators. Double-blind, dose-response placebo-controlled multicenter study of nisoldipine. Circulation 1991; 84: 2398–408.
Frishman WH, Heiman M. Usefulness of oral nisoldipine for stable angina pectoris. The Nisoldipine Multicenter Angina Study Group. Am J Cardiol 1991; 68: 1004–9.
Serruys PW, Suryapramata H, Planellas J, Wijus W, Vanhaleweyk GLJ, Soward A, Jaski BE, Hugenholtz PG. Acute effects of intavenous nisoldipine on left ventricular function and coronary hemodynamics. Am J Cardiol 1985; 56: 140–6.
Tartagni F, Ruggiero S, Melandri G, Beato E, Dondi M, Monetti N, Magnani B. Effects of oral nisoldipine in ischemic heart disease. Drug Res 1986; 36: 1528–31.
Mertes H, Erbel R, Nixdorff U, Mohr-Kahaly S, Wölfinger D, Meyer J. Stress echocardiography: A sensitive method for the detection of coronary artery disease. Herz 1991; 16: 355–66.
Mertes H, Erbel R, Nixdorff U, Mohr-Kahaly S, Krüger S, Meyer J. Exercise echocardiography for the evaluation of patients after nonsurgical coronary artery revascularization. J Am Coll Cardiol 1993; 21: 1087–93.
Nixdorff U, Meyer J. Echocardiography for monitoring the effects of reperfusion therapy in myocardial infarction. L'inform Cardiol 1996; 20: 43–51.
Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, El-Said E-SM, du Bois NAJJ, Roelandt JRTC, van Urk H. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993; 87: 1506–12.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger J, Siverman NH, Tajik AJ. Recommendations for the quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358–67.
Fox K, Pool J, Vos J, Lubsen J. The effects of nisoldipine on the total ischaemic burden: the results of the ROCKET study. Eur Heart J 1991; 12: 1283–7.
Aldrich HR, Reichek N. Stress echocardiography. Curr Opin Cardiol 1993; 8: 978–87.
Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expression of ischemia. Am J Cardiol 1987; 57: 23c–30c.
Tennant T, Wiggers CJ. Effects of coronary occlusion on myocardial contraction. Am J Physiol 1935; 112: 351–61.
Marwick TH, Nemec JJ, Pashkow FJ, Stewart WJ, Salcedo EE. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992; 19: 74–81.
Crouse LJ, Kramer PH. Clinical applicability of echocardiographically detected regional wall-motion abnormalities provoked by upright treadmill exercise. Echocardiography 1992; 9: 97–106.
McConahay DR, McCallister BD, Smith RE. Postexercise electrocardiography: correlations with coronary arteriography and left ventricular hemodynamics. Am J Cardiol 1971; 28: 1–9.
Scognamiglio R, Pouchia A, Fasoli G, Miraglia G, DallaVolta S. Exercise-induced left ventricular dysfunction in coronary heart disease. A model for studying the stunned myocardium in man. Eur Heart J 1991; 12(Suppl): 16–9.
Leischik R, Adamczewski O, Pötter S, Erbel R, Lösse B. Exercise echocardiography — a new test for the assessment of antiischemic drug effects. Z Kardiol 1995; 84: 621–32.
Heusch G, Guth BD, Seitelberger R, Ross J Jr. Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nisoldipine. Circulation 1987; 75: 482–90.
Dymond DS, Caplin JL, D'Keefe JC, Banim S. Effects of nisoldipine on left ventricular function during exercise or cold pressor stress. Eur Heart J 1987; 8(Suppl K): 27–33.
Kattus AA. Exercise electrocardiography: recognition of the ischemic response, false positive and negative patterns. Am J Cardiol 1974; 33: 721–31.
Marx BE, Bertel O, Amann FW. Late recurrent ischaemia in infarct patients with a normal predischarge exercise test after thrombolysis. Eur Heart J 1990; 11: 897–902.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nixdorff, U., Erbel, R., Wagner, S. et al. Dynamics stress echocardiography for evaluating anti-ischemic drug profiles in post-MI patients. Int J Cardiovasc Imaging 13, 485–491 (1997). https://doi.org/10.1023/A:1005882829544
Issue Date:
DOI: https://doi.org/10.1023/A:1005882829544